Tomasini, Davide
 Distribuzione geografica
Continente #
NA - Nord America 2.293
AS - Asia 1.222
EU - Europa 900
SA - Sud America 198
Continente sconosciuto - Info sul continente non disponibili 54
AF - Africa 34
OC - Oceania 3
Totale 4.704
Nazione #
US - Stati Uniti d'America 2.235
SG - Singapore 474
CN - Cina 297
IT - Italia 290
BR - Brasile 167
DE - Germania 158
HK - Hong Kong 145
VN - Vietnam 90
FI - Finlandia 60
PL - Polonia 60
GB - Regno Unito 59
UA - Ucraina 56
FR - Francia 55
BD - Bangladesh 53
TR - Turchia 47
IN - India 45
RU - Federazione Russa 43
IE - Irlanda 30
CA - Canada 22
ID - Indonesia 15
MX - Messico 15
NL - Olanda 15
CZ - Repubblica Ceca 14
SE - Svezia 13
AR - Argentina 12
IQ - Iraq 12
ES - Italia 11
ZA - Sudafrica 11
TN - Tunisia 8
JM - Giamaica 7
JP - Giappone 7
MA - Marocco 7
EG - Egitto 6
AT - Austria 5
CH - Svizzera 5
LT - Lituania 5
AL - Albania 4
EC - Ecuador 4
PK - Pakistan 4
AU - Australia 3
BO - Bolivia 3
CO - Colombia 3
GT - Guatemala 3
HN - Honduras 3
IL - Israele 3
JO - Giordania 3
LV - Lettonia 3
OM - Oman 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BE - Belgio 2
CY - Cipro 2
EE - Estonia 2
GR - Grecia 2
KZ - Kazakistan 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
SA - Arabia Saudita 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EU - Europa 1
IR - Iran 1
IS - Islanda 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 4.651
Città #
Ashburn 297
Singapore 266
Fairfield 182
San Jose 173
Chandler 158
Hong Kong 144
Los Angeles 89
New York 88
Beijing 78
Seattle 75
Woodbridge 69
Houston 68
Wilmington 61
Munich 60
Warsaw 56
Brescia 54
The Dalles 52
Cambridge 48
Jacksonville 48
Princeton 46
Helsinki 43
Dallas 40
Milan 40
Ho Chi Minh City 37
Council Bluffs 35
Lauterbourg 32
Dublin 30
Istanbul 29
Shanghai 29
Chicago 21
Columbus 21
Santa Clara 20
Buffalo 19
Ann Arbor 16
Des Moines 16
Frankfurt am Main 16
São Paulo 16
San Diego 15
San Francisco 15
Hanoi 13
Jakarta 13
Denver 12
Orem 12
Redondo Beach 12
Boardman 11
Nuremberg 11
Turku 11
Washington 11
Brno 10
Dong Ket 10
London 10
Romola 10
Chennai 9
Montreal 9
Phoenix 9
Moscow 8
Rome 8
Atlanta 7
Dearborn 7
Tokyo 7
Erbil 6
Guangzhou 6
Johannesburg 6
Kingston 6
Lappeenranta 6
Lumezzane 6
Mexico City 6
New Delhi 6
Poplar 6
Rio de Janeiro 6
Toronto 6
Bengaluru 5
Boston 5
Brooklyn 5
Changsha 5
Cremona 5
Düsseldorf 5
Kyiv 5
Manchester 5
Naples 5
Amsterdam 4
Ankara 4
Cairo 4
Delhi 4
Haiphong 4
Nanjing 4
Nashville 4
Paris 4
Porto Alegre 4
Salt Lake City 4
Tianjin 4
Tirana 4
Augusta 3
Biên Hòa 3
Brasília 3
Calvisano 3
Camposano 3
Can Tho 3
Charlotte 3
Chongqing 3
Totale 2.995
Nome #
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 224
Metabolic behavior and prognostic role of pretreatment 18F-FDG PET/CT in gist 206
Intra-fraction and Inter-fraction analysis of a dedicated immobilization device for intracranial radiation treatment 171
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 163
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 163
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 163
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 163
18F-Fluciclovine (18F-FACBC) PET/CT or PET/MRI in gliomas/glioblastomas 161
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma 154
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis 151
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 146
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 142
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 141
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 139
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 136
18F-FDG PET or PET/CT role in plasmacytoma: A systematic review 135
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 135
Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial 134
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 133
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients 129
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study 114
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience 114
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment 110
Letter to the editor regarding “Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable” 110
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients 104
Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy 104
Prevention and management of acute esophageal toxicity during concomitant chemoradiotherapy for locally advanced lung cancer 103
Sparing of swallowing-related organs in radiotherapy for oropharyngeal squamous cell carcinoma 101
Post-HIFU locally relapsed prostate cancer: high-dose salvage radiotherapy guided by molecular imaging 101
Treatment of loco-regional recurrence of nasopharyngeal carcinoma in a non-endemic area: oncologic outcomes, morbidity, and proposal of a prognostic nomogram 93
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspective 93
Radiolabelled PSMA PET/CT in breast cancer. A systematic review 92
Impact of Dosimetric Parameters on Tumor Control in Stereotactic Radiotherapy for Pancreatic Cancer: A Prospective Study on 104 Patients Treated with Simultaneous Integrated Protection (SIP) 90
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience 86
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal's letter to the editor 80
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 70
Stereotactic Radiotherapy and Androgen Deprivation Therapy for Localized Prostate Cancer: A Retrospective Mono-institutional Experience 50
Totale 4.704
Categoria #
all - tutte 26.218
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.218


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022194 0 23 2 9 4 15 10 13 12 31 11 64
2022/2023404 38 18 18 32 47 80 12 46 60 3 33 17
2023/2024483 31 8 59 22 22 90 27 32 84 20 20 68
2024/2025879 15 19 18 132 65 88 60 38 107 71 167 99
2025/20261.838 183 207 118 242 198 130 259 70 112 153 93 73
2026/202796 64 32 0 0 0 0 0 0 0 0 0 0
Totale 4.704